QA: Karuna Therapeutics Inc in us_pharma/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001771917_2022_Karuna_Therapeutics_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001771917, Karuna Therapeutics Inc

  xvar xval
0 AssetsCurrent 517,334,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 3,092,000
3 remainder_Assets 7,245,000
4 LiabilitiesCurrent 20,213,000
5 LiabilitiesNoncurrent 5,432,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 52,617,000
9 ResearchAndDevelopmentExpense 128,200,000
10 remainder_Expenses 6,000
11 remainder_Revenues 36,964,000
12 remainder_NetIncome 54,000
13 remainder_ComprehensiveNetIncome -536,000
  yvar yval
0 Assets 527,671,000
1 Liabilities 25,645,000
2 Expenses 180,823,000
3 Revenues 36,964,000
4 StockholdersEquity 502,026,000
5 NetIncome -143,805,000
6 ComprehensiveNetIncome -144,073,000
7 BaseVar 385,846,500
8 EconomicCapitalRatiobeforeLimitedLiability 3.44
9 EconomicCapitalRatio 3.98

Edgar->Model Mapping

Feature Distribution

Change over Time